Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Gilead Sciences Inc (GILD)

67.38 -0.15 (-0.22%)

05-25 16:00

Open:

67.65

Pre. Close:

67.53

High:

67.93

Low:

67

Volume:

3,961,619

Market Cap:

87612M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

67.959 - 68.416

68.416 - 68.795

Low:

66.116 - 66.565

66.565 - 66.938

Close:

66.722 - 67.451

67.451 - 68.056

Technical analysis  (as of: 2018-05-25 4:35:13 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 82.32     One year: 86.81

Support:

Support1: 64.27    Support2: 53.47

Resistance:

Resistance1: 70.48    Resistance2: 74.32

Pivot:

66.87

Moving Averages:

MA(5): 67.71     MA(20): 67.27

MA(100): 76.06     MA(250): 75.28

MACD:

MACD(12,26): -1.28     Signal(12,26,9): -1.69

%K %D:

%K(14,3): 76.75     %D(3): 75.26

RSI:

RSI(14): 40.02

52-Week:

High: 89.54  Low: 63.76  Change(%): 4.5

Average Vol(K):

3-Month: 712170  10-Days 574000

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
GILD has closed below upper band by 38.1%. Bollinger Bands are 47.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to GILD's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-25T12:21:17-04:00
Rounds Report: CryoPort Rallied While The FDA Approved Palynziq

2018-05-25T09:00:00-04:00
Mining For ASCO 2018's Gold, Part 3: Making Money In The Brain

2018-05-24T21:34:03-04:00
'Safer' Dividend Healthcare Top WallStar Gainers Are Gilead, Sanofi, Amerisource, Anthem, And Johnson, Per Broker May Targets

2018-05-24T13:00:53-04:00
The No. 1 Stock In The World (Revisited) - Visa And Apple Up, Kinder Morgan And Gilead Down

2018-05-24T12:24:11-04:00
Top Wall Street Healthcare Gainers For May: Allergan, CVS Health, Patterson, Sanofi, And Gilead

2018-05-24T03:49:06-04:00
Gilead: Novartis's Kymriah Is Coming To America

2018-05-23T16:01:00-04:00
Gilead Sciences to Present at the Jefferies 2018 Healthcare Conference on Wednesday, June 6

2018-05-23T12:28:47-04:00
High Rates And Inflation Could Pose A Systemic Risk To Biotech

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

1300.26

Shares Float (M)

1293.12

% Held by Insiders

0.50

% Held by Institutions

81.50

Shares Short (K)

16126

Shares Short Prior Month (K)

19600

Stock Financials

EPS

7.710

EPS Est. Current Year

8.790

EPS Est. Next Year

7.340

EPS Est. Next Quarter

1.900

Forward EPS

6.477

Book Value (p.s.)

4.130

PEG Ratio

-1.52

Profit Margin

14.35

Operating Margin

51.83

Return on Assets (ttm)

5.6

Return on Equity (ttm)

16.9

Qtrly Rev. Growth

-21.8

Gross Profit (p.s.)

12.450

Sales Per Share

EBITDA (p.s.)

8.740

Qtrly Earnings Growth

-43.10

Operating Cash Flow (M)

11240.00

Levered Free Cash Flow (M)

9750.00

atoplab.com

Valuation

P/E

8.74

P/E Growth Ratio

P/BV

16.31

P/S

4637056512.00

P/CF

7.79

Dividend Yield

0.05

Dividends & Splits

Dividend

3.446

Dividend Pay Date

2018-06-28

Ex-Dividend Date

2018-06-14

Forward Dividend

2.280

Last Split Date

2013-01-28

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.